WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Thomas HendersonChief Executive Officer2026-02-1111,494$62.96
$723.66kSell
Michael Thomas HendersonChief Executive Officer2026-02-11955$64.99
$62.07kSell
Michael Thomas HendersonChief Executive Officer2026-02-117,551$63.73
$481.23kSell
Carl DambkowskiChief Medical Officer2026-02-044,125$22.86
$94.30kBuy
Carl DambkowskiChief Medical Officer2026-02-04200$68.94
$13.79kSell
Carl DambkowskiChief Medical Officer2026-02-04100$67.88
$6.79kSell
Carl DambkowskiChief Medical Officer2026-02-041,299$66.85
$86.84kSell
Carl DambkowskiChief Medical Officer2026-02-041,420$65.83
$93.48kSell
Carl DambkowskiChief Medical Officer2026-02-042,481$64.88
$160.97kSell
Jane HendersonChief Financial Officer2026-02-021,108$66.15
$73.29kSell

1 of 7

APGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vr Adviser LLC12.43%8,493,321$596.83MInstitution
Fmr LLC12.04%8,225,038$577.97MInstitution
Wellington Management Group LLP6.95%4,746,585$333.54MInstitution
Blackrock Inc5.54%3,783,994$265.90MInstitution
Vanguard Group Inc4.18%2,857,824$200.82MInstitution
Rtw Investments LP3.97%2,712,097$190.58MInstitution
Perceptive Advisors LLC3.41%2,330,651$163.77MInstitution
Driehaus Capital Management LLC3.20%2,183,704$153.45MInstitution
Janus Henderson Group PLC3.02%2,062,604$144.94MInstitution
Fairmount Funds Management LLC3.00%2,048,647$143.96MInstitution

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE94.74%5.26%Net SellingNet Selling
TGTX57.68%42.32%Net SellingNet Selling
SRRK60.17%39.83%Net BuyingNet Buying
CGON85.26%14.74%Net BuyingNet Buying
CELC80.20%19.80%Net BuyingNet Selling
View Top Biotech Stocks

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 100.30% institutional shareholders, 5.57% Apogee Therapeutics insiders, and 0.00% retail investors. Nimish P. Shah is the largest individual Apogee Therapeutics shareholder, owning 1.75M shares representing 2.56% of the company. Nimish P. Shah's Apogee Therapeutics shares are currently valued at $120.63M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.